![Researchers Meenakshisundaram Balasubramaniam (from left), Ph.D.; Srikanth Vallurupalli, M.D.; Robert J. Shmookler Reis, Ph.D.; Srinivas Ayyadevara, Ph.D.; and Akshatha Ganne are shown in their research laboratory at the UAMS Donald W. Reynolds Institute on Aging. Ganne was the lead author of the study published in the journal Aging Biology.](https://news.uams.edu/wp-content/uploads/2024/08/UAM_6386-560x315.jpg)
UAMS Researchers Discover Cholesterol Drug’s Potential as Treatment for Alzheimer’s, Other Dementia
Aug. 6, 2024 | Researchers from the University of Arkansas for Medical Sciences (UAMS) have discovered that an FDA-approved cholesterol drug holds the potential to disrupt the progression of Alzheimer’s disease and other forms of dementia. The research team published its findings in the journal Aging Biology. Akshatha Ganne, a postdoctoral fellow in the UAMS College of Medicine’s Department...